In the past month there has been a steady stream of positive news coming from Laredo Petroleum Inc, cost cutting measures, new Board appointments and improved efficiency have helped build investor confidence. On May 2nd results and earnings were very positive, with higher than expected production for a lower cost. Currently trading at very low P/E 2.13 this...
On the top of our watchlist for the next week, speculation is rife about merger next week. Trade setup as per the chart. AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include...
Expectations are so low for Weight watchers and negativity is at a all time high,so it may just be the perfect conditions for a nice pop in earnings. Any good news what so ever will have a very positive effect on investor sentiment. This is a risky long but placing our stop lose on support offers a good RR on the trade. If the trade would happen to go against us...
On the 30th April Fuelcell Energy announced a new project which sent the stock 20% higher, we are looking for continuation in the name which has really been beaten down. Cash concerns have inflicted a lot of skepticism on the company but several Institutional investors have recently added to their positions in the stock. Blackrock added 10.5% to their position in...
Medicine Man Technologies is a fully integrated operator in the cannabis industry, offering consulting, cultivation supplies and equipment, retail pharma-grade products, and turnkey solutions for cannabis producers, processors and retailers for nearly a decade. Medicine Man Technologies is leveraging its expertise and intellectual property to vertically integrate...
This is purely on our watch-list for continuation of the buying activity already taken place, on news of restructuring within the company. Emerge Energy Services LP engages in the ownership, operation, acquisition and development of a diversified portfolio of energy service assets. It also engages in the businesses of mining, processing, and distributing silica...
Sentiment has been very positive in ALDEYRA THERAPEUTICS having already released positive results for other pipeline drugs. On may 1st phase 2 results for its new Dry Eye Syndrome drug will be presented and optimism is high on the rumor mill. The current price target by 7 analysts covering the name is $31 which is considerable higher than current levels....
Interest in Silk Road Medical will be sure to intensify this week as news-flow is expected. Since the IPO, buying has continued in the name and analysts interest will increase the volume and bullish sentiment. We see this as a great company with huge opportunity. Silk Road Medical, Inc. operates as a medical device company in the United States. It offers ENROUTE...
This chart and the price action is a thing of beauty. The price had a break above resistance and has now tested that level on multiple occasions before continuing higher. We foresee a breakout from the pennant in the near future possibly on earnings, in our opinion the chart is extremely bullish. Currently 5 analysts cover the company and have a average price...
Over the past month few months speculation and accumulation in CFMS has drawn out attention. Conformis, Inc is a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting...
Don't worry that you missed out on this initial move in the price, still plenty of room to run for ZYNERBA PHARMA, which specializes in the development and commercialism of cannabis treatments for conditions ranging from Epilepsy and Osteoarthritis. Although the stock has had a considerable move this month, it is still a low cap company with huge potential, so...
There are no riches at the end of this chart, just endless misfortune for investors besotted with the speculation of a possible deal with APPLE to integrate WATT wireless charging into all new phones. In February 2019 WATT did announce a deal with Chinese smartphone maker VIVO and the stock plunged on the news. Unless there is some signs of earnings or a deal that...
A bumper earnings report and upbeat outlook rewarded they faithful with a lovely 21% pop on considerably large volume today. These shares do tend to be very volatile but today in particularly with a earnings surprise of 16% and a sense of relief that this could be the start of a much larger move in consumer optimism.
After quite a dismal performance, today was a welcome relief to investors. Results were mixed but confidence was taken from the revenue increases and a pass was given to a decline in profits due to increased costs, in particular labor expenses. This looks like a nice risk reward long but look for continuation in price action first.
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in children, adolescents, and adults.
April 2019 PHUN was awarded patent approval for new location system which could possibly be used in gaming, this sent the stock soaring. More good news followed, the announcement of a new partnership with Endpoint IP to license PHUN's 16 patented technologies takes the company one step closer to generating income. There is considerable speculation regarding more...
The rumor mill continues to spin in ATOS prior to a presentation scheduled for April the 25th, the spike in volume hopefully preempts a positive move. Keep it on the watchlist.
This is a pure Bitcoin related watchlist stock for us, RIOT has built a nice base in the past year and is now sitting at resistance, we will go long on a break and expect great volatility, nimble trading required for sure, short on any weakness in BTC.